The investigation of homovanillic acid in the human brain and its correlation to senile dementia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

The investigation of homovanillic acid in the human brain and its correlation to senile dementia

Abstract

References

Metatyrosine as a tool for selective protection of catecholamine stores against reserpine

Reversal of the reserpine-induced suppression of the conditioned avoidance response in the cat by L-DOPA

Further evidence for the existence of tubero-infundibular dopamine neurons

Stereotype hyperactive behaviour produced by dopamine in the absence of noradrenaline

The concentration of adrenaline in human plasma and its relation to mental activity

Excretion of dopamine in diseases of basal ganglia

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome

SOEME OBSERVATIONS ON ADRENERGIC CONNECTIONS BETWEEN MESENCEPHALON AND CEREBRAL HEMISPHERES

DISTRIBUTION OF HOMOVANILLIC ACID IN THE HUMAN BRAIN

FURTHER EVIDENCE FOR THE PRESENCE OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS IN THE RAT

IDENTIFICATION AND CELLULAR LOCALIZATION OF THE CATECHOLAMINES IN THE RETINA AND THE CHOROID OF THE RABBIT

Dopamine (3-hydroxytyramine) in the central nervous system and its relation to the Parkinson syndrome in man

A family with Alzheimer's disease

Citations

Neurochemical aspects on aging and diseases with cognitive impairment

Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL)

Dopamine metabolites in human brain

Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment

A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease

Brain dopamine D-2 receptors in senile dementia

Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature

Increased CSF HVA response to arecoline challenge in Alzheimer's disease

Monoamine acid metabolites in ventricular CSF of patients with brain tumours

Monoamines and related metabolite levels in the cerebrospinal fluid of patients with dementia of Alzheimer type. Influence of treatment with L-deprenyl

The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease

Distribution of monoamines in human brain: evidence for neurochemical heterogeneity in subcortical as well as in cortical areas

The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia

Cerebrospinal fluid homovanillic acid in Huntington's chorea

Brain dopamine D-1 receptors in senile dementia

Distribution of biogenic amines and their catabolites in brains from patients with Alzheimer's disease

Monoaminergic neurotransmitters in Alzheimer's disease. An HPLC study comparing presenile familial and sporadic senile cases

Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sex

Clinical measurements of central dopamine and 5-hydroxytryptamine metabolism: reliability and interpretation of cerebrospinal fluid acid monoamine metabolite measures

Short-term memory in the rhesus monkey: effects of dopamine blockade via acute haloperidol administration

Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT)

Multiple biochemical deficits in both gray and white matter of Alzheimer brains

Memantine in the treatment of senile dementia of the Alzheimer type

Neurotransmitter synthetic enzymes

Special chemistry of the basal ganglia I. Monoamines

Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys

Vascular disease, senility, and dementia

Orphan neurones and amine excess: the functional neuropathology of Parkinsonism and neuropsychiatric disease

Biochemical changes in the cholinergic system of the ageing brain and in senile dementia

Catecholamines and neurologic diseases (second of two parts)

Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism

Lowered monoamine oxidase activity in brains from alcoholic suicides

Studies of the monoamine metabolism in the central nervous system in Jakob-Creutzfeldt disease

Grave lithium intoxication with fatal outcome

Cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid in huntington's chorea

Treatment with disulfiram in huntington's chorea

Dihydropteridine reductase activity in dried blood spots: effects of aging and senile dementia of the Alzheimer type

CSF monoamine metabolites in old age dementias

Acute administration of individual optimal dose of physostigmine fails to improve mnesic performances in Alzheimers Presenile Dementia

Risk factors for neuroleptic-induced movement disorders

Late effects on rabbit brain morphology and monoamine metabolites produced by 60C0-irradiation.

Soluble proteins in normal and diseased human brain.

Regional distribution of monoamines and their metabolites in the human brain

Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease

Person-centredness and its association with resident well-being in dementia care units

Evidence for the contribution by the cerebral cortex to 5-hydroxyindoleacetic acid found in the cerebrospinal fluid of cats

Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia

Monoamines and their metabolites in cerebrospinal fluid of patients with senile dementia of Alzheimer type using high performance liquid chromatography and gas chromatography-mass spectrometry

Monoamine oxidase activity in normal and Alzheimer brains

Biochemistry of Alzheimer's dementia

Related Concepts

Related Feeds

Basal Ganglia

Related Papers

Levodopa treatment of presenile dementia.

Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism

Acid monoamine metabolites in cerebrospinal fluid from patients with presenile dementia (Alzheimer's disease)

Cerebrospinal fluid pH and monoamine and glucolytic metabolites in Alzheimer's disease

Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia